Research

Packages

Life of the unit

Next seminars

Last publications

Updated

Régis Bouquié

Situation

Poste : AHU
Institution : UFR de Médecine - Université de Nantes

Publications scientifiques

Articles dans une revue internationale

• 1. Victorri-Vigneau C, Verstuyft C, Bouquié R, Laforgue E, Hardouin JB, Leboucher J, Le Geay B, Dano C, Challet G, Grall-Bronnec M (2019) Relevance of CYP2B6 and CYP2D6 genotypes to methadone pharmacokinetics and response in the OPAL study. British Journal of Clinical Pharmacology, 85(7): 1538-1543.
  
  
• 2. Victorri-Vigneau C, Rousselet M, Grall-Bronnec M, Bouquié R, Belliot E, Guerlais M, Guillet JY, Jolliet P (2016) Use of Psychotropic Drug Urine Test Strips in Opiate Maintenance Therapy: A Clinical Assessment of Its Advantages. Substance Abuse, 37(4): 584-90.
  
  
• 3. Bouquié R, Hernando H, Deslandes G, Ben Mostefa Daho A, Renaud C, Grall-Bronnec M, Dailly E, Jolliet P (2015) Chiral on-line solid phase extraction coupled to liquid chromatography-tandem mass spectrometry assay for quantification of (R) and (S) enantiomers of methadone and its main metabolite in plasma. Talanta, 134: 373-378.
  
  
• 4. Wainstein L, Bernier C, Gérardin M, Bouquié R, Espitia O, Mussini J, Jolliet P, Victorri-Vigneau C (2015) Livedo-like dermatitis and necrotic lesions after high-dose buprenorphine injections : a national French survey. Brit J Dermatol, 172: 10412-4.
  
  
• 5. Bouquié R, Deslandes G, Nieto-Bernaldez B, Renaud C, Dailly E, Jolliet P (2014) A fast LC-MS/MS assay for methotrexate monitoring in plasma: validation, comparison to FPIA and application in the setting of carboxypeptidase therapy . Anal Methods , 6: 178-186.
  
  
• 6. Allavena C, Dailly E, Reliquet V, Bonnet B, Pineau S, Andre-Garnier E, Boutoille D, Bouquié R, Raveleau A, Bouchez S, Billaud E, Raffi F (2014) Switching from Tenofovir/Emtricitabine and Nevirapine to Tenofovir/Emtricitabine/Rilpivirine Single Tablet Regimen in Virologically Suppressed, HIV-1 Infected Subjects . J Antimicrob Chemother, 69: 2804-2808.
  
  
• 7. Dailly E, Allavena C, Deslandes G, Bouquié R, Jolliet P, Raffi F (2014) Clinical relevance of the interaction when switching non-nucleoside reverse transcriptase inhibitors in patients infected with HIV . Curr Clin Pharmacol., 9: 399-403.
  
  
• 8. Bouquié R, Wainstein L, Pilet P, Mussini J, Deslandes G, Clouet J, Dailly E, Jolliet P, Victorri-Vigneau C (2014) Crushed and injected buprenorphine tablets : characteristics of princeps and generic solutions. Plos One, 9: e113991.
  
  
• 9. Gregoire M, Deslandes G, Renaud C, Bouquié R, Allavena C, Raffi F, Jolliet P, Dailly E (2014) A liquid chromatography-tandem mass spectrometry assay for quantification of rilpivirine and dolutegravir in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci, 971: 1-9.
  
  
• 10. Dailly E, Arnould J, Fraissinet F, Naux E, Letard de la Bouralière M, Bouquié R, Deslandes G, Jolliet P, Le Floch R (2013) Pharmacokinetics of ertapenem in burns patients. Int J Antimicrob Agents, 42: 48-52.
  
  
• 11. Dailly E, Fraissinet F, Deslandes G, Bouquié R, Jolliet P (2013) Evaluation of the QMS® Teicoplanin Immunoassay (ThermoFisher Scientific) on Cobas® 8000 System (Roche Diagnostics) and comparison to fluorescence polarization immunoassay for the determination of Teicoplanin concentrations in human plasma . J Clin Lab Anal, 27: 96-8.
  
  
• 12. Dailly E, Allavena C, Bouquié R, Deslandes G, Raffi F, Jolliet P (2013) Effect of efavirenz, nevirapine, etravirine, raltegravir administration on the pharmacokinetics of ritonavir-boosted darunavir in a population of HIV-infected Patients. AIDS Research and Human Retroviruses , 29(29): 42-46.
  
  
• 13. Bouquié R, Deslandes G, Renaud C, Dailly E, Jolliet P (2013) Validation and application of a fast semi-automated whole blood extraction for LC-MS/MS simultaneous quantification of cyclosporine A, tacrolimus, sirolimus and everolimus - Application to high throughput routine therapeutic drug monitoring. . Anal Methods , 5: 5079-5088.
  
  
• 14. Dailly E, Rodallec A, Allavena C, Deslandes G, Garnier E, Billaud E, Ferré V, Reliquet V, Bouquié R, Raffi F, Jolliet P (2012) Virological response to darunavir in patients infected with HIV is linked to darunavir resistance–associated mutations corrected by the count of mutations with positive impact and is not associated with pharmacological and combined virological/pharmacolog. Fundamental and Clinical Pharmacology, 26(4): 538-542.
  
  
• 15. Dailly E, Rodallec A, Allavena C, Deslandes G, Garnier E, Billaud E, Ferré V, Reliquet V, Bouquié R, Raffi F, Jolliet P (2012) Virogical response to darunavir in patients infected with HIV is linked to darunavir resistance-associated mutations corrected by the count of mutations with positive impact and is not associated with pharmacovigical and combined virogical/pharmacological. Fundamental&clinical pharmacology, 26(4): 538-542.
  
  
• 16. Dailly E, Bouquié R, Deslandes G, Jolliet P, Le Floch R (2011) A liquid chromatography assay for a quantification of doripenem, ertapenem, imipenem, meropenem concentrations in human plasma: application to a clinical pharmacokinetic study. Analyt Technol Biomed Life, 879(15): 1137-1142.
  
  
• 17. Bouquié R, Deslandes G, Renaud C, Dailly E, Haloun A, Jolliet P (2011) Colchicine-induced rhabdomyolysis in a heart/lung transplant patient with concurrent use of ciclosporine, pravastatin and azithromycin. Journal of Clinical Rheumatology: .
  
  
• 18. Bouquié R, Bonnin A, Bernardeau k, Khammari A, Dréno B, Labarriere N, Lang F (2009) A fast and efficient HLA multimer-based sorting procedure that induces little apoptosis to isolate clinical grade human tumor specific T lymphocytes. Cancer Immunol Immunotherapie: .
  
  
• 19. Labarriere N, Gervois N, Bonnin A, Bouquié R, Jotereau N, Lang F (2008) PBMC are as good a source of tumor-reactive T lymphocytes as TIL after selection by MelanA/A2 multimer sorting. Cancer Immunol Immunotherapie: .
  
  

Chapitres d'ouvrage

• 1. Ghosn J, Bouquié R, Viard J, Potel G (2014) Principales classes d’antibiotiques , d’antiviraux, d’antifongiques et d’antiparasitaires Prescription et surveillance. . In Dans Le bon usage du médicament et des thérapeutiques non médicamenteuses ; collection des enseignants Editions Med-line (): 0.
  
  

Articles dans une revue nationale

• 1. Gregoire M, Boutoleau-Bretonnière C, Deslandes G, Monteil-Ganière C, Bouquié R, Dailly E, Renaud C, Azoulay C, Pineau A, Grison-Hernando H, Jolliet P (2014) Early lactic acidosis following massive acetaminophen poisoning: a metabolic disorder sometimes unknown [L’acidose lactique précoce lors de l’intoxication massive au paracetamol: un trouble métabolique parfois méconnu] . Toxicologie Analytique et Clinique : sous presse.
  
  
• 2. Deslandes G, Bouquié R, Boels D, Gregoire M, Grison-Hernando H, Azoulay C, Pineau A, Monteil-Ganière C, Renaud C, Dailly E, Harry P, Jolliet P (2014) Accidental poisoning with brimonidine eye drops in a 9-day-old infant . Toxicologie Analytique et Clinique : sous presse.
  
  
• 3. Dailly E, Papuchon E, Deslandes G, Bouquié R, Jolliet P, Cantarovich D (2013) Modified mycophenolic acid pharmacokinetics after replacement of tacrolimus by sirolimus following simultaneous pancreas/kidney transplantation. Journal of Applied Biopharmaceutics and Pharmacokinetics , 1: 1-4.
  
  
• 4. Dailly E, Verdier M, Deslandes G, Bouquié R, Tribut O, Bentué-Ferrer D (2012) Level of evidence for Therapeutic Drug Monitoring of ceftriaxone. Thérapie, 67(2): 145-149.
  
  
• 5. Dailly E, Bouquié R, Bentué-Ferrer D (2010) Therapeutic Drug Monitoring of Levetiracetam. Thérapie, 17: 28-30.
  
  
• 6. Bouquié R, Dailly E, Bentué-Ferrer D (2010) Therapeutic Drug Monitoring of Oxcarbazepine. Thérapie, 65: 67-70.
  
  

Participations à des projets

• OPAL : Etude multicentrique évaluant la prévalence des co-addictions chez des sujets bénéficiant d’un traitement de substitution aux opiacés. Détermination du profil clinique et pharmacologique
  
  

Communications scientifiques

Poster dans un colloque international (idpers=656)

• 1. Bouquié R., Deslandes G., Dailly E., Jolliet P. Heterogeneity of pholcodine dosing recommendations in paediatric population according to the French drug compendium specifications. 7èmes Congrès de Physiologie, pharmacologie et thérapeutique, 4-6 avril 2012, Dijon, 2012.
  
  
• 2. Dailly E., Arnould J., Fraissinet F., Naud E., Letard de la Bouralière M., Bouquié R., Deslandes G., Jolliet P., Le Floch R. Pharmacokinetics of ertapenem in burn patients. 7èmes Congrès de Physiologie, pharmacologie et thérapeutique, 4-6 avril 2012, Dijon, 2012.
  
  
• 3. Dailly E., Bouquié R., Deslandes G., Jolliet P., Le Floch R. A liquid chromatography assay for a simultaneous quantification of imipenem, doripenem, ertapenem, meropenem concentrations in human plasma: application to a clinical pharmacokinetic study in burn patients (preliminary results). 6ème Congrès Commun de Physiologie, Pharmacologie et Thérapeutique, 22-24 mars 2011, Grenoble, 2011.
  
  
• 4. Bouquié R., Deslandes G., Renaud C., Dailly E., Jolliet P. A fast semi-automated whole blood extraction of immunosupressive drugs applicable to therapeutic drug monitoring : preliminary result with tacrolimus and cyclosporin A. e Ph5ème Congrès Commun dysiologie, Pharmacologie et Thérapeutique, 23-25 mars 2010, Bordeaux, 2010.
  
  
• 5. Deslandes G., Dailly E., Bouquié R., Lodé L., Renaud C., Jolliet P. Rapid quantification of imatinib in human plasma by high-performance liquid chromatography tandem mass spectrometry with on-line extraction. e Ph5ème Congrès Commun dysiologie, Pharmacologie et Thérapeutique, 23-25 mars 2010, Bordeaux, 2010.
  
  
• 6. Deslandes G., Bouquié R., Dailly E., Renaud C., Jolliet P. In-source transformation of drug metabolites: a matter to identify when using liquid chromatography electrospray tandem-mass spectrometry. e Ph5ème Congrès Commun dysiologie, Pharmacologie et Thérapeutique, 23-25 mars 2010, Bordeaux, 2010.
  
  
• 7. Dailly E., Deslandes G., Bouquié R., Allavena C., Raffi F., Jolliet P. Effects of protease inhibitors (lopinavir, darunavir and atazanavir) administration on trough plasma concentrations of raltegravir in experienced patients infected with VIH. e Ph5ème Congrès Commun dysiologie, Pharmacologie et Thérapeutique, 23-25 mars 2010, Bordeaux, 2010.
  
  
• 8. Deslandes G., Dailly E., Bouquié R., Renaud C., Jolliet P. Simultaneous determination of voriconazole, posaconazole, itraconazole and hydroxy-itraconazole concentration in human plasma by a liquid chromatography-tandem mass spectrometry assay with on-line extraction. e Ph5ème Congrès Commun dysiologie, Pharmacologie et Thérapeutique, 23-25 mars 2010, Bordeaux, 2010.
  
  

Communications orales dans un colloque national (idpers=656)

• 1. Victorri-Vigneau C., Verstuyft C., Laforgue E., Bouquié R., Hardouin J.B., Leboucher J., Challet G., Grall-Bronnec M. Impact du polymorphisme du CYP2B6 sur la pharmacocinétique et la réponse clinique de sujets recevant de la méthadone. 10es Ateliers de pharmacodépendance et addictovigilance, Biarritz 15-16 octobre 2018, Thérapie, 2018, 73(6): 563, 2018.
  
  
• 2. Bouquié R. Complications vasculaires: Atteintes cutanées suite à l’injection IV de buprénorphine. 7èmes Congrès de Physiologie, pharmacologie et thérapeutique, 4-6 avril 2012, Dijon, 2012.
  
  

Poster dans un colloque national (idpers=656)

• 1. Bouquié R., Deslandes G., Renaud C., Dailly E., Haloun A., Jolliet P. Rhabdomyolyse sous colchicine : A propos d'un cas chez un patient transplanté coeur/poumons traité par ciclosporine, azithromycine et pravastatine. 6èmes Congrès de Physiologie, pharmacologie et thérapeutique, 22-24 mars 2011, Grenoble, 2011.
  
  
• 2. Bouquié R., Deslandes G., Billaud E., Hourmant M., Dailly E., Jolliet P. Interactions attendues et inattendues entre antirétroviraux et tacrolimus, à propos d'un cas. 30ème Réunion Interdisciplinaire de Chimiothérapie Anti-Infectieuse; 2-3 décembre 2010, Paris, 2010.
  
  
• 3. Deslandes G., Bouquié R., Talarmin J., Dailly E., Jolliet P. Perfusion continue d’amoxicilline : suivi thérapeutique ou pas ?. e Ph5ème Congrès Commun dysiologie, Pharmacologie et Thérapeutique, 23-25 mars 2010, Bordeaux, 2010.